Cryo-Cell Q2 revenue falls as processing, storage fees decline - CCEL News | RalliesCryo-Cell Q2 revenue falls as processing, storage fees decline
C
CCEL• Quarterly results
- US cord blood bank's fiscal Q2 revenue fell 2% yr/yr to $7.8 mln
- Net income for fiscal Q2 rose to $555,000 from $356,000 a year earlier
- Revenue decline driven by lower processing and storage fee revenue
Outlook and analyst coverage
- Cryo-Cell International did not provide specific guidance for the current quarter or full year
- The one available analyst rating on the shares is "hold"
- The average consensus recommendation for the healthcare facilities & services peer group is "buy."
